La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

OssDsign Bilan de santé

Santé financière contrôle des critères 6/6

OssDsign possède un total de capitaux propres de SEK224.4M et une dette totale de SEK599.0K, ce qui porte son ratio d'endettement à 0.3%. Son actif total et son passif total sont SEK313.9M et de SEK89.5M.

Informations clés

0.2%

Ratio d'endettement

SEK 471.00k

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	SEK 118.79m
Fonds propres	SEK 224.85m
Total du passif	SEK 81.61m
Total des actifs	SEK 306.46m

Mises à jour récentes de la santé financière

We Think OssDsign (STO:OSSD) Can Afford To Drive Business Growth

Aug 06

Here's Why We're Not Too Worried About OssDsign's (STO:OSSD) Cash Burn Situation

Aug 19

Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

Feb 23

Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

Jul 15

Recent updates

We Think OssDsign (STO:OSSD) Can Afford To Drive Business Growth

Aug 06

Increases to OssDsign AB (publ)'s (STO:OSSD) CEO Compensation Might Cool off for now

Jun 19

Getting In Cheap On OssDsign AB (publ) (STO:OSSD) Is Unlikely

Mar 19

Here's Why We're Not Too Worried About OssDsign's (STO:OSSD) Cash Burn Situation

Aug 19

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de OSSD ( SEK175.4M ) dépassent ses passifs à court terme ( SEK32.0M ).

Passif à long terme: Les actifs à court terme de OSSD ( SEK175.4M ) dépassent ses passifs à long terme ( SEK57.5M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: OSSD dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de OSSD a été réduit de 5.4% à 0.3% au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: OSSD dispose d'une piste de trésorerie suffisante pour plus d'un an sur la base de son flux de trésorerie disponible actuel.

Prévisions de trésorerie: OSSD dispose d'une marge de trésorerie suffisante pour plus de 3 ans si le flux de trésorerie disponible continue de diminuer à un taux historique de 3 % chaque année

OssDsign Bilan de santé

Santé financière contrôle des critères 6/6

Informations clés

Mises à jour récentes de la santé financière

We Think OssDsign (STO:OSSD) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About OssDsign's (STO:OSSD) Cash Burn Situation

Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

OssDsign AB (publ) Ordinary Shares to Be Deleted from OTC Equity

Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

Recent updates

Second quarter 2024 earnings: EPS misses analyst expectations

We Think OssDsign (STO:OSSD) Can Afford To Drive Business Growth

OssDsign AB (publ) Approves Election of Christer Fåhraeus as Ordinary Board Member

Increases to OssDsign AB (publ)'s (STO:OSSD) CEO Compensation Might Cool off for now

OssDsign AB (publ) to Report Fiscal Year 2023 Final Results on Jun 04, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

OssDsign AB (publ) to Report Fiscal Year 2023 Final Results on May 22, 2024

No longer forecast to breakeven

Getting In Cheap On OssDsign AB (publ) (STO:OSSD) Is Unlikely

OssDsign AB (publ.) Appoints Tom Buckland as Chief Technical Officer

New minor risk - Share price stability

Forecast breakeven date moved forward to 2024

OssDsign AB (publ), Annual General Meeting, May 21, 2024

Consensus EPS estimates fall by 30%, revenue upgraded

Forecast breakeven date moved forward to 2024

OssDsign AB (publ.) Announces 12-Month Data from the Clinical Study Top Fusion

OssDsign AB (publ) to Report Q3, 2024 Results on Nov 05, 2024

OssDsign AB (publ) Reports Exceptional Data from the Clinical Study TOP FUSION

Ossdsign AB (Publ) Provides Revenue Guidance for the Fourth Quarter of 2023

An Unknown buyer acquired 7.6% stake in OssDsign AB (publ) (OM:OSSD).

OssDsign AB (publ) to Report Fiscal Year 2023 Results on Feb 06, 2024

OssDsign AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 150.000003 million.

OssDsign AB (publ) Announces All Activities Pertaining to the Patient-Specific Cranial Implant Business Will Be Discontinued in A Responsible Manner by the End of December 2023

OssDsign Receives FDA Clearance for A New Major Indication

Consensus EPS estimates fall by 15%

Consensus estimates of losses per share improve by 14%

Second quarter 2023 earnings released: kr0.30 loss per share (vs kr0.40 loss in 2Q 2022)

Here's Why We're Not Too Worried About OssDsign's (STO:OSSD) Cash Burn Situation

Forecast breakeven date moved forward to 2024

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

No longer forecast to breakeven

Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

Full year 2022 earnings released: kr1.70 loss per share (vs kr1.94 loss in FY 2021)

OssDsign AB (publ) to Report Fiscal Year 2022 Results on Feb 21, 2023

Forecast to breakeven in 2025

OssDsign AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 65.63568 million.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

OssDsign AB (publ) Ordinary Shares to Be Deleted from OTC Equity

High number of new directors

Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

OssDsign AB (publ) Elects Jill Shiaparelli as Board Member

Consensus forecasts updated

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to kr14.00

Insufficient new directors

Consensus revenue estimates fall by 16%

Chief Executive Officer recently bought kr133k worth of stock

Chief Executive Officer recently bought kr133k worth of stock

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Full year 2021 earnings: EPS and revenues exceed analyst expectations

OssDsign AB (publ), Annual General Meeting, Jun 02, 2022

Insufficient new directors

OssDsign AB (publ.) Receives Approval to Establish Clinical Registry in the U.S. to Collect Real-World Data on OssDsign Catalyst

Forecast to breakeven in 2024

OssDesign AB (Publ.) Announces Updated Clinical Data from A Long-Term Follow-Up of the Company's Innovative Product OssDsign Cranial PSI, Which Is Used in the Treatment of Cranial Bone Defects

Chief Executive Officer recently bought kr124k worth of stock

Third quarter 2021 earnings released: kr0.30 loss per share (vs kr1.10 loss in 3Q 2020)

Second quarter 2021 earnings released: kr0.40 loss per share (vs kr1.30 loss in 2Q 2020)

Independent Chairman of the Board recently bought kr150k worth of stock

Consensus EPS estimates increase to -kr3.00

Price target decreased to kr17.33

Chief Executive Officer recently bought kr210k worth of stock

Chief Executive Officer recently bought kr388k worth of stock

Ossdsign AB (Publ) Announces Innovative Synthetic Bone Graft Outperforms a Comparable Device in Bone Formation Following Spinal Fusion Surgery

Chief Financial Officer recently bought kr214k worth of stock

OssDsign AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 240.506091 million.

Chief Financial Officer recently bought kr298k worth of stock

New Scientific Paper Further Confirms Osteointegration of OssDsign Cranial PSI Implants